Home/Filings/4/0001209191-22-053411
4//SEC Filing

Kwan Rudolf 4

Accession 0001209191-22-053411

CIK 0001300699other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 8:11 AM ET

Size

21.6 KB

Accession

0001209191-22-053411

Insider Transaction Report

Form 4
Period: 2022-10-07
Kwan Rudolf
EVP, Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-10-07$0.24/sh+20,340$4,900362,064 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $4.55From: 2017-06-12Exp: 2024-06-12Common Stock (48,000 underlying)
    48,000
  • Stock Option (Right to Buy)

    Exercise: $11.00From: 2020-06-13Exp: 2027-06-13Common Stock (140,000 underlying)
    140,000
  • Stock Option (Right to Buy)

    Exercise: $3.80Exp: 2031-08-03Common Stock (70,000 underlying)
    70,000
  • Stock Option (Right to Buy)

    Exercise: $0.67Exp: 2032-07-20Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Buy)

    Exercise: $5.50From: 2018-12-16Exp: 2024-12-16Common Stock (200,000 underlying)
    200,000
  • Stock Option (Right to Buy)

    Exercise: $17.30From: 2022-03-27Exp: 2028-03-27Common Stock (120,000 underlying)
    120,000
  • Stock Option (Right to Buy)

    Exercise: $4.55From: 2018-05-13Exp: 2023-05-13Common Stock (48,000 underlying)
    48,000
  • Stock Option (Right to Buy)

    Exercise: $7.50From: 2019-05-22Exp: 2025-05-22Common Stock (120,000 underlying)
    120,000
  • Stock Option (Right to Buy)

    Exercise: $4.55From: 2016-01-02Exp: 2023-01-02Common Stock (96,000 underlying)
    96,000
  • Stock Option (Right to Buy)

    Exercise: $4.55From: 2018-02-12Exp: 2024-02-12Common Stock (120,000 underlying)
    120,000
  • Stock Option (Right to Buy)

    Exercise: $12.45Exp: 2030-06-05Common Stock (140,000 underlying)
    140,000
  • Stock Option (Right to Buy)

    Exercise: $13.17Exp: 2029-02-28Common Stock (120,000 underlying)
    120,000
  • Restricted Stock Units

    Common Stock (52,500 underlying)
    52,500
Footnotes (7)
  • [F1]Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
  • [F2]This option vests in four equal annual installments beginning on February 28, 2020.
  • [F3]This option vests in four equal annual installments beginning on June 5, 2021.
  • [F4]The option vests in four equal annual installments beginning on August 3, 2022.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of stock.
  • [F6]The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
  • [F7]This option vests in four equal annual installments beginning on July 20, 2023.

Issuer

Athenex, Inc.

CIK 0001300699

Entity typeother

Related Parties

1
  • filerCIK 0001708965

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 8:11 AM ET
Size
21.6 KB